| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33076 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56573SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-07034SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44806 | |||
| Azide and BSA Free | NBP2-34694-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56179SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-81832-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-35333SS | |||
| Azide and BSA Free | NBP2-80622 | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX0180A488-100 | |||
| Alexa Fluor 546 | DDX0180A546-100 | |||
| Alexa Fluor 647 | DDX0180A647-100 | |||
| Biotin | DDX0180B-100 | |||
![Immunohistochemistry-Paraffin: IL-2 Antibody [NBP2-16948] - Human tonsil. Image from verified customer review.](http://images.novusbio.com/fullsize/IL-2-Antibody-Immunohistochemistry-Paraffin-NBP2-16948-img0006.jpg "Immunohistochemistry-Paraffin: IL-2 Antibody [NBP2-16948] - Human tonsil. Image from verified customer review.")
![Flow Cytometry: IL-2 Antibody [NBP2-16948] - THP-1 cell. Black: Unlabelled sample was used as a control. Red: IL2 antibody dilution: 1:50. Acquisition of 20,000 events were collected for FACS analysis.](http://images.novusbio.com/fullsize/IL-2-Antibody-Flow-Cytometry-NBP2-16948-img0007.jpg)
![Immunohistochemistry-Paraffin: IL-2 Antibody [NBP2-16948] - Human gastric cancer, using IL2 antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/IL-2-Antibody-Immunohistochemistry-Paraffin-NBP2-16948-img0004.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: IL-2 Antibody [NBP2-16948] -Untreated (-) and treated (+) Jurkat E6.1 whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with IL2 antibody diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/antibody/nbp2-16948_rabbit-polyclonal-il-2-antibody-western-blot-1742024104643.jpg)
![TIRAP (TLR2 and TLR4) Inhibitor Peptide [NBP2-26245] - TLR2 acts through formation of heterodimer complexes with TLR1 or TLR6. HEK 293 endogenously expresses TLR1 and TLR6, so that the TLR2 reporter cell line can response to both Pam3CSK4 (TLR2/TLR1 specific ligand) and MALP-2 (TLR2/TLR6 specific ligand). The TLR2 / TLR4 inhibitor specifically inhibits TLR2/TLR1 receptor complex activity in a dose-response manner but exhibited no or little effect on TLR2/TLR6 receptor complex activity.](http://images.novusbio.com/fullsize/TIRAP-TLR2-and-TLR4-Inhibitor-Peptide-NBP2-26245-img0007.jpg "TIRAP (TLR2 and TLR4) Inhibitor Peptide [NBP2-26245] - TLR2 acts through formation of heterodimer complexes with TLR1 or TLR6. HEK 293 endogenously expresses TLR1 and TLR6, so that the TLR2 reporter cell line can response to both Pam3CSK4 (TLR2/TLR1 specific ligand) and MALP-2 (TLR2/TLR6 specific ligand). The TLR2 / TLR4 inhibitor specifically inhibits TLR2/TLR1 receptor complex activity in a dose-response manner but exhibited no or little effect on TLR2/TLR6 receptor complex activity.")
![TIRAP (TLR2 and TLR4) Inhibitor Peptide [NBP2-26245] - The TLR4 reporter cell line responds to LPS. The TLR2 / TLR4 inhibitor specifically inhibits TLR4 activation upon LPS stimulation in a dose-response manner.](http://images.novusbio.com/fullsize/TIRAP-TLR2-and-TLR4-Inhibitor-Peptide-NBP2-26245-img0008.jpg)
![TIRAP (TLR2 and TLR4) Inhibitor Peptide [NBP2-26245] - TLR2 /4 Inhibitor suppressed the Pam3CSK4-induced TLR2/TLR1 activity [A] and the LPS-induced TLR4 activity [B] in a dose-response manner, of which IC50 values were measured as 17.2 uM and 10.47 uM, respectively.](http://images.novusbio.com/fullsize/TIRAP-TLR2-and-TLR4-Inhibitor-Peptide-NBP2-26245-img0009.jpg)
![Flow Cytometry: CD34 Antibody (ICO-115) [NBP2-29455] - Analysis using the PE conjugate of NBP2-29455. Surface Staining of CD34 on KG-1 cells using CD34 antibody (red) and isotype control (green) at 5 ul/0.5 ug/10^6 cells. PPI negative cell population was gated for analysis.](http://images.novusbio.com/fullsize/CD34-Antibody-ICO-115-Flow-Cytometry-NBP2-29455-img0002.jpg "Flow Cytometry: CD34 Antibody (ICO-115) [NBP2-29455] - Analysis using the PE conjugate of NBP2-29455. Surface Staining of CD34 on KG-1 cells using CD34 antibody (red) and isotype control (green) at 5 ul/0.5 ug/10^6 cells. PPI negative cell population was gated for analysis.")
![Flow Cytometry: CD34 Antibody (ICO-115) [NBP2-29455] - Surface flow cytometric analysis of CD34 on KG-1 cells using CD34 antibody (red) and isotype control (green) at 0.5 ug/10^6 cells.](http://images.novusbio.com/fullsize/CD34-Antibody-ICO-115-Flow-Cytometry-NBP2-29455-img0001.jpg)
![Western Blot: TLR2 Antibody [NB100-56573] - Analysis of TLR2 in (A) 15 ugs of Raw cell lysate (B) Mouse TLR2 transfected cell lysate and (C) Ramos cell lysate. 1 ug/ml.](http://images.novusbio.com/fullsize/TLR2-Antibody-Western-Blot-NB100-56573-img0001.jpg "Western Blot: TLR2 Antibody [NB100-56573] - Analysis of TLR2 in (A) 15 ugs of Raw cell lysate (B) Mouse TLR2 transfected cell lysate and (C) Ramos cell lysate. 1 ug/ml.")
![Western Blot: CCL2/MCP1 Antibody [NBP1-07034] - Analysis of recombinant mouse MCP1. Image provided via product review by verified customer.](http://images.novusbio.com/fullsize/CCL2-MCP1-Antibody-Western-Blot-NBP1-07034-img0004.jpg "Western Blot: CCL2/MCP1 Antibody [NBP1-07034] - Analysis of recombinant mouse MCP1. Image provided via product review by verified customer.")
![Western Blot: CCL2/MCP1 Antibody [NBP1-07034] - Analysis of MCP1 in Hela whole cell lysates.](http://images.novusbio.com/fullsize/CCL2-MCP1-Antibody-Western-Blot-NBP1-07034-img0003.jpg)
![Immunohistochemistry-Paraffin: CD63 Antibody (NKI/C3) [NBP2-32829] - Formalin-fixed, paraffin-embedded Mouse Spleen stained with (DAB Chromogen)](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Immunohistochemistry-Paraffin-NBP2-32829-img0010.jpg "Immunohistochemistry-Paraffin: CD63 Antibody (NKI/C3) [NBP2-32829] - Formalin-fixed, paraffin-embedded Mouse Spleen stained with (DAB Chromogen)")
![Western Blot: CD63 Antibody (NKI/C3) [NBP2-32829] - Characterization of exosomes from HIV-infected T cells. CD63 and CD9 immunoblot (left) and AChE assays (right) of J1.1 exosomes isolated from 2, 10, and 20 ml of culture supernatants. Image collected and cropped by Citeab from the following publication (Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun (2018) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Western-Blot-NBP2-32829-img0012.jpg)
![Western Blot: CD63 Antibody (NKI/C3) [NBP2-32829] - Characterization of exosomes from HIV-infected T cells. Immunoblot of CD63, CD9, and CD81 on proteins extracted from T-cell line exosomes (whole scans of blots in Supplementary Figure 1). Image collected and cropped by Citeab from the following publication (Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun (2018) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Western-Blot-NBP2-32829-img0013.jpg)
![Flow Cytometry: CD63 Antibody (NKI/C3) [NBP2-32829] - Flow cytometry Analysis of live MCF-7 cells unstained (gray) or stained with biotin-labeled CD63 monoclonal antibody (NKI-C3) followed by streptavidin-CF568 (orange).](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Flow-Cytometry-NBP2-32829-img0016.jpg)
![Immunohistochemistry-Paraffin: CD63 Antibody (NKI/C3) [NBP2-32829] - Formalin-fixed, paraffin-embedded human Melanoma stained with CD63 Antibody (NKI/C3) (AEC Chromogen)](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Immunohistochemistry-Paraffin-NBP2-32829-img0009.jpg)
![Flow Cytometry: CD63 Antibody (NKI/C3) [NBP2-32829] - Human CD63 on MCF-7 cells. Black: Cells alone; Green: Isotype Control; Red: PE-labeled CD63 Monoclonal Antibody (NKI/C3).](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Flow-Cytometry-NBP2-32829-img0005.jpg)
![Flow Cytometry: CD63 Antibody (NKI/C3) [NBP2-32829] - Flow Cytometric Analysis of U8G cells using PE-labeled CD63 Monoclonal Antibody (NKI/C3) Isotype Control (Red).](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Flow-Cytometry-NBP2-32829-img0015.jpg)
![Western Blot: TRAF-6 Antibody [NB100-56179] - Analysis of TRAF-6 in normal Human tissues using this antibody. TRAF6 is observed at ~66 kDa. Additional bands of lower molecular weight were seen in some cases, and may represent TRAF-6 degradation fragments.](http://images.novusbio.com/fullsize/TRAF-6-Antibody-Western-Blot-NB100-56179-img0011.jpg "Western Blot: TRAF-6 Antibody [NB100-56179] - Analysis of TRAF-6 in normal Human tissues using this antibody. TRAF6 is observed at ~66 kDa. Additional bands of lower molecular weight were seen in some cases, and may represent TRAF-6 degradation fragments.")
![Immunohistochemistry-Paraffin: TRAF-6 Antibody [NB100-56179] - Stained for TRAF6 using this antibody at 1:2000. Hematoxylin-eosin counterstain. A, mouse spleen. B, mouse thymus.](http://images.novusbio.com/fullsize/TRAF-6-Antibody-Immunohistochemistry-Paraffin-NB100-56179-img0008.jpg)
![Immunohistochemistry-Paraffin: TRAF-6 Antibody [NB100-56179] - 1:2000. Analysis Hematoxylin-eosin counterstain. A, mouse lymph node. B, mouse bone marrow.](http://images.novusbio.com/fullsize/TRAF-6-Antibody-Immunohistochemistry-Paraffin-NB100-56179-img0007.jpg)
![Western Blot: MIF Antibody [NBP1-81832] - Analysis in human cell lines HEK293 and U-251MG using Anti-MIF antibody. Corresponding MIF RNA-seq data are presented for the same cell lines. Loading control: Anti-HSP90B1](http://images.novusbio.com/fullsize/MIF-Antibody-Western-Blot-NBP1-81832-img0013.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: MIF Antibody [NBP1-81832] - Analysis in human cell lines HEK293 and U-251MG using Anti-MIF antibody. Corresponding MIF RNA-seq data are presented for the same cell lines. Loading control: Anti-HSP90B1")
![<b>Orthogonal Strategies Validation. </b>Western Blot: MIF Antibody [NBP1-81832] - Expression and purification of MaMIF. Western blot analysis with isotype-matched primary antibody shows the background level of antibody binding to the protein. Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-019-51947-7), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/MIF-Antibody-Western-Blot-NBP1-81832-img0020.jpg)
![Immunocytochemistry/Immunofluorescence: MIF Antibody [NBP1-81832] - Staining of human cell line U-251 MG shows localization to cytosol. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/MIF-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-81832-img0015.jpg)
![Immunohistochemistry-Paraffin: MIF Antibody [NBP1-81832] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/MIF-Antibody-Immunohistochemistry-Paraffin-NBP1-81832-img0019.jpg)
![Western Blot: MIF Antibody [NBP1-81832] - Western blot analysis in mouse cell line NIH-3T3, rat cell line NBT-II and rat cell line pC12.](http://images.novusbio.com/fullsize/MIF-Antibody-Western-Blot-NBP1-81832-img0011.jpg)
![Immunohistochemistry-Paraffin: MIF Antibody [NBP1-81832] - Staining of human fallopian tube shows strong cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/MIF-Antibody-Immunohistochemistry-Paraffin-NBP1-81832-img0016.jpg)
![Immunohistochemistry-Paraffin: MIF Antibody [NBP1-81832] - Staining of human kidney moderate cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/MIF-Antibody-Immunohistochemistry-Paraffin-NBP1-81832-img0017.jpg)
![Immunohistochemistry-Paraffin: MIF Antibody [NBP1-81832] - Staining of human prostate shows moderate cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/MIF-Antibody-Immunohistochemistry-Paraffin-NBP1-81832-img0018.jpg)
![Western Blot: MIF Antibody [NBP1-81832] - Expression & purification of MaMIF. (A) SDS-PAGE analysis of purified MaMIF suggesting an approximate molecular mass of ~12.5 kDa for the monomer. (B) Superdex 75 10/300 GL analytical size-exclusion chromatography profile of MaMIF suggesting an apparent molecular mass of ~39 kDa in solution, corresponding to the size of a trimeric form. (C) CD spectrum of MaMIF confirming a properly folded protein. The pie chart in the inset shows the secondary structure make-up of the protein. (D) Western blot analysis with polyclonal anti-His & anti-MIF antibodies confirming the expressed protein to be MaMIF. (E) Western blot analysis with isotype-matched primary antibody shows the background level of antibody binding to the protein. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31664114), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-81832_rabbit-polyclonal-mif-antibody-31020241534334.jpg)
![Western Blot: CCR2 Antibody (2D8) [NBP2-35333] - Analysis of CCR2 [2D8] in Molt4 lysate](http://images.novusbio.com/fullsize/CCR2-Antibody-2D8-Western-Blot-NBP2-35333-img0003.jpg "Western Blot: CCR2 Antibody (2D8) [NBP2-35333] - Analysis of CCR2 [2D8] in Molt4 lysate")
![Immunohistochemistry-Paraffin: CCR2 Antibody (2D8) [NBP2-35333] - Analysis of FFPE tissue section of human esophageal squamous cell carcinoma (SCC) using CCR2 antibody (clone 2D8) at 5 ug/ml concentration. The cancer cells depicted strong cytoplasmic-membranous immunostaining, whereas the cells of tumor stroma were largely negative for CCR2 immunopositivity.](http://images.novusbio.com/fullsize/CCR2-Antibody-2D8-Immunohistochemistry-Paraffin-NBP2-35333-img0002.jpg)
![Immunohistochemistry-Paraffin: CCR2 Antibody (2D8) [NBP2-35333] - Analysis of FFPE tissue section of human breast using CCR2 antibody (clone 2D8) at 5 ug/ml concentration. The glandular cells in the lobules showed a specific cytoplasmic-membranous immunostaining, whereas, the inter-lobular connective tissue did not develop any staining for CCR2.](http://images.novusbio.com/fullsize/CCR2-Antibody-2D8-Immunohistochemistry-Paraffin-NBP2-35333-img0001.jpg)
![Western Blot: IFIT2 Antibody [NBP1-31164] - p115 and Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA and DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.ppat.1002747) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Western-Blot-NBP1-31164-img0006.jpg "Western Blot: IFIT2 Antibody [NBP1-31164] - p115 and Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA and DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.ppat.1002747) licensed under a CC-BY license.")
![Western Blot: IFIT2 Antibody [NBP1-31164] - Sample(30 ug of whole cell lysate)A:A431 B:Hep G2 7.5% SDS PAGE, antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Western-Blot-NBP1-31164-img0003.jpg)
![Western Blot: IFIT2 Antibody [NBP1-31164] - p115 & Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA & DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115 (A) or Sec16A (B) & non-targeting (NT) control shRNA for 24 h followed by puromycin selection (1.5 µg/ml) for 5 days. Cells were left untreated or stimulated with poly I:C (1 µg/ml), poly dA:dT (1 µg/ml) or SeV (200 HAU/ml) for 16 h. Whole-cell lysates were prepared & subjected to immunoblot analysis with indicated antibodies. One of two independent experiments with similar results is shown. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/22792062), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-31164_rabbit-polyclonal-ifit2-antibody-310202415171321.jpg)
![IFIT2 antibody [N1], N-term detects IFIT2 protein at endoplasmic reticulum by immunofluorescent analysis.Sample: HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min.Green: IFIT2 protein stained by IFIT2 antibody [N1], N-term (NBP1-31164) diluted at 1:200.Red: alpha Tubulin, a cytoskeleton marker, stained by alpha Tubulin antibody [B-5-1-2] diluted at 1:10000.Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/nbp1-31164_rabbit-polyclonal-ifit2-antibody-immunocytochemistry-immunofluorescence-1411202518351210.jpg)
![Western Blot: PBEF/Visfatin/NAMPT Antibody [NB100-594] - Samples: Whole cell lysate (50 ug) from HeLa, RKO, MCF-7, TCMK-1, and NIH 3T3 cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-PBEF antibody used for WB at 0.04 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-Western-Blot-NB100-594-img0015.jpg "Western Blot: PBEF/Visfatin/NAMPT Antibody [NB100-594] - Samples: Whole cell lysate (50 ug) from HeLa, RKO, MCF-7, TCMK-1, and NIH 3T3 cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-PBEF antibody used for WB at 0.04 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.")
![Immunohistochemistry-Paraffin: PBEF/Visfatin/NAMPT Antibody [NB100-594] - Section of human head and neck squamous cell carcinoma. Antibody: Affinity purified rabbit anti-PBEF used at a dilution of 1:5,000 (0.2ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-Immunohistochemistry-Paraffin-NB100-594-img0016.jpg)
![Western Blot: PBEF/Visfatin/NAMPT Antibody [NB100-594] - Samples: Whole cell lysate (1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-PBEF antibody used for IP at 6 ug per reaction. PBEF was also immunoprecipitated by a previous lot of this antibody and rabbit anti-Visfatin antibody. For blotting immunoprecipitated PBEF, Antibody was used at 0.04 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-Western-Blot-NB100-594-img0014.jpg)
![Immunohistochemistry: DCIR/CLEC4A Antibody (111F8.04) [DDX0180P-100] - IHC staining of human tonsil frozensection with 111F8 (X1000)](http://images.novusbio.com/fullsize/DCIR-CLEC4A-Antibody-111F8-04-Immunohistochemistry-DDX0180P-100-img0011.jpg "Immunohistochemistry: DCIR/CLEC4A Antibody (111F8.04) [DDX0180P-100] - IHC staining of human tonsil frozensection with 111F8 (X1000)")
![Flow Cytometry: DCIR/CLEC4A Antibody (111F8.04) [DDX0180P-100] - FACS staining of monocytederivedDCs(GM+IL4) with111F8](http://images.novusbio.com/fullsize/DCIR-CLEC4A-Antibody-111F8-04-Flow-Cytometry-DDX0180P-100-img0010.jpg)
![Immunohistochemistry-Paraffin: DCIR/CLEC4A Antibody (111F8.04) [DDX0180P-100] - C-type lectin with a tyrosine based inhibitory motif](http://images.novusbio.com/fullsize/DCIR-CLEC4A-Antibody-111F8-04-Immunohistochemistry-Paraffin-DDX0180P-100-img0003.jpg)
![Flow (Cell Surface): DCIR/CLEC4A Antibody (111F8.04) [DDX0180P-100] - Analysis using the PE conjugate of DDX0180P-100. Staining of DCIR (shaded histogram) in human PBMCs using the monocyte population gated using forward and side scatter with DDX0180PE at 1ug/ml (A) and 3 ug/ml (B). Open histogram is isotype control.](http://images.novusbio.com/fullsize/DCIR-CLEC4A-Antibody-111F8-04-Flow-Cell-Surface-DDX0180P-100-img0006.jpg)